39 studies found for:
" December 16, 2009":" January 15, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
Preventative Misconception Intervention
|
||||
| 2 | Unknown † |
A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance
|
||||
| 3 | Completed |
Cell Phone Reminders Intervention
|
||||
| 4 | Active, not recruiting |
Treatment for Depression Among HIV-Infected Youth
|
||||
| 5 | Recruiting |
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
|
||||
| 6 | Recruiting |
High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk
|
||||
| 7 | Recruiting |
Medications for Chronic HIV: Education and Collaboration
|
||||
| 8 | Recruiting |
Isentress Re-examination Study (MK-0518-115 AM1)
|
||||
| 9 | Terminated |
Pre-Exposure Prophylaxis Using TMC278LA
|
||||
| 10 | Completed |
TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions
|
||||
| 11 | Terminated |
Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens
|
||||
| 12 | Completed |
The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
|
||||
| 13 | Completed |
Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study
|
||||
| 14 | Completed |
Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
|
||||
| 15 | Unknown † |
Notification of Donors With Positive Microbiology Markers
|
||||
| 16 | Completed |
MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use
|
||||
| 17 | Unknown † |
A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects
|
||||
| 18 | Completed |
Management of HIV-1 Patients Treated With Antiretroviral Combination Therapy Including Raltegravir (MK0518-138)
|
||||
| 19 | Completed |
Observational Study of Blood Treated With Cytolin
|
||||
| 20 | Unknown † |
Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy
|
† Indicates status has not been verified in more than two years
